Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCaledonia Regulatory News (CLDN)

Share Price Information for Caledonia (CLDN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3,390.00
Bid: 3,380.00
Ask: 3,400.00
Change: 20.00 (0.59%)
Spread: 20.00 (0.592%)
Open: 3,380.00
High: 3,400.00
Low: 3,380.00
Prev. Close: 3,370.00
CLDN Live PriceLast checked at -
Caledonia is an Investment Trust

To grow net assets and dividends over the long term, whilst managing risk to avoid permanent loss of capital.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Caledon Resources Plc

6 Jan 2011 16:46

FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A
PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
Rule 8.3 of the Takeover Code (the "Code")
1. KEY INFORMATION
(a) Identity of the person whose positions/dealings
are being disclosed: Loeb Arbitrage Management LP
(b) Owner or controller of interests and short
positions disclosed, if different from 1(a):
The naming of nominee or vehicle companies is
insufficient.
(c) Name of offeror/offeree in relation to whose
relevant securities this form relates: Caledon Resources Plc
Use a separate form for each offeror/offeree
(d) If an exempt fund manager connected with an
offeror/offeree, state this and specify identity of
offeror/offeree:
(e) Date position held/dealing undertaken: 04 January 2011
(f) Has the discloser previously disclosed, or are they
today disclosing, under the Code in respect of any NO
other party to this offer? If YES, specify which:
2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE
(a) Interests and short positions in the relevant securities of the offeror or offeree to
which the disclosure relates following the dealing (if any)
Class of relevant security: Ordinary
Interests Short positions
Number (%) Number (%)
(1) Relevant securities owned
and/or controlled:
(2) Derivatives (other than
options) 2,130,924 .95%
(3) Options and agreements to
purchase/sell
TOTAL: 2,130,924 .95%
All interests in short positions should be disclosed.
Details of any open derivative or option positions, or agreements to purchase or sell relevant
securities, should be given on a Supplemental Form 8 (Open Positions).
(b) Rights to subscribe for new securities (including directors' and other executive
options)
Class of relevant security in relation to
which subscription right exists:
Details, including nature of the rights
concerned and relevant percentages:
If there are positions or rights to subscribe to disclose in more than one class of relevant securities
of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional
class of relevant security.
3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE
(a) Purchases and sales
Class of relevant Purchase/sale Number of securities Price per unit
security
(b) Derivatives transactions (other than options)
Class of Product Nature of dealing Number of Price per
relevant description e.g. opening/closing a reference unit
security e.g. CFD long/short position, securities
increasing/reducing a
long/short position
Ordinary shares CFD Decreasing long position 500,000 97.6877 GBp
(c) Options transactions in respect of existing securities
(i) Writing, selling, purchasing or varying
Class Product Writing, Number of Exercise Type Expiry Option
of description purchasing, securities price e.g. date money
relevant e.g.call selling, to which per unit American, paid/
security option varying etc. option European received
relates etc. per unit
(ii) Exercising
Class of relevant Product description Number of securities Exercise price per
security e.g. call option unit
(d) Other dealings (including subscribing for new securities)
Class of relevant Nature of dealing Details Price per unit
security e.g. subscription, conversion (if applicable)
The currency of all prices and other monetary amounts should be stated.
Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.
4. OTHER INFORMATION
(a) Indemnity and other dealing arrangements
Details of any indemnity or option arrangement, or any agreement or understanding,
formal or informal, relating to relevant securities which may be an inducement to deal or
refrain from dealing entered into by the person making the disclosure and any party to the
offer or any person acting in concert with a party to the offer:
If there are no such agreements, arrangements or understandings, state "none"
NONE
(b) Agreements, arrangements or understandings relating to options or derivatives
Details of any agreement, arrangement or understanding, formal or informal, between the
person making the disclosure and any other person relating to:
(i) the voting rights of any relevant securities under any option; or
(ii) the voting rights or future acquisition or disposal of any relevant securities to which
any derivative is referenced:
If there are no such agreements, arrangements or understandings, state "none"
NONE
(c) Attachments
Is a Supplemental Form 8 (Open Positions) attached? NO
Date of disclosure: January 6, 2011
Contact name: Alex McMillan
Telephone number: 212-483-7069

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

Copyright Business Wire 2011

Date   Source Headline
13th Jun 20244:00 pmRNSAnnual Financial Report
7th Jun 20245:22 pmRNSDirector/PDMR Shareholding
6th Jun 20243:28 pmRNSDirector/PDMR Shareholding
6th Jun 20249:39 amRNSNet Asset Value(s)
30th May 20242:55 pmRNSDirector/PDMR Shareholding
21st May 20247:00 amRNSFinal Results
7th May 202410:40 amRNSNet Asset Value(s)
1st May 20247:00 amRNSTotal Voting Rights
1st May 20247:00 amRNSTransaction in Own Shares
29th Apr 20247:00 amRNSTransaction in Own Shares
22nd Apr 20247:00 amRNSNotice of annual results
22nd Apr 20247:00 amRNSTransaction in Own Shares
15th Apr 20247:00 amRNSTransaction in Own Shares
8th Apr 20247:30 amRNSTransaction in Own Shares
8th Apr 20247:00 amRNSUnaudited net asset value and portfolio update
2nd Apr 20247:01 amRNSTotal Voting Rights
2nd Apr 20247:00 amRNSTransaction in Own Shares
28th Mar 20243:19 pmRNSTransaction in Own Shares
25th Mar 20247:00 amRNSTransaction in Own Shares
22nd Mar 202410:32 amRNSDirector Declaration
6th Mar 20242:33 pmRNSNet Asset Value(s)
20th Feb 20245:02 pmRNSDirector/PDMR Shareholding
7th Feb 20241:31 pmRNSNet Asset Value(s)
30th Jan 20243:58 pmRNSDirector/PDMR Shareholding
19th Jan 20244:30 pmRNS2023 AGM results update statement
18th Jan 202411:56 amRNSDisposal
8th Jan 20247:00 amRNSUnaudited net asset value and portfolio update
7th Dec 20232:19 pmRNSNet Asset Value(s)
29th Nov 202311:49 amRNSDirector/PDMR Shareholding
27th Nov 20234:37 pmRNSDirector/PDMR Shareholding
21st Nov 20237:00 amRNSHalf-year Report
14th Nov 20233:28 pmRNSNotice of Half-Year Results
7th Nov 20237:00 amRNSNet Asset Value(s)
6th Oct 20237:00 amRNSUnaudited net asset value and portfolio update
28th Sep 20233:28 pmRNSDirector/PDMR Shareholding
25th Sep 202310:58 amRNSDirector/PDMR Shareholding
20th Sep 20239:56 amRNSDirector/PDMR Shareholding
8th Sep 20234:34 pmRNSDirector/PDMR Shareholding
7th Sep 20231:50 pmRNSDirector/PDMR Shareholding
5th Sep 20237:00 amRNSCaledonia signs agreement to sell 7IM
7th Aug 20237:00 amRNSNet Asset Value(s)
19th Jul 20235:53 pmRNSResult of AGM
7th Jul 202310:22 amRNSNet Asset Value and Portfolio Update
15th Jun 20234:01 pmRNSAnnual Financial Report
9th Jun 20235:27 pmRNSDirector/PDMR Shareholding
6th Jun 202310:44 amRNSNet Asset Value(s)
1st Jun 20233:23 pmRNSDirector/PDMR Shareholding
23rd May 20237:00 amRNSDirectorate Change
23rd May 20237:00 amRNSFinal Results
9th May 20232:16 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.